Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Study design
1.1.2. Indication
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Virtual Clinical Trials Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. COVID-19 pandemic impact on clinical trial activity
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. The growing role of technology in healthcare
3.4.1.2. Benefits of virtual trials
3.4.1.3. Government support
3.4.2. Market Restraint Analysis
3.4.2.1. Data Security
3.4.3. Industry Challenge
3.5. Virtual Clinical Trials: Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
Chapter 4. Virtual Clinical Trials Market: Segment Analysis, By Study Design, 2016 - 2027 (USD Million)
4.1. Segment Dashboard
4.2. Study Design Market Share Analysis, 2019 & 2027
4.3. Global Virtual Clinical Trials Market, By Study Design, 2016 to 2027
4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following:
4.4.1. Interventional
4.4.2. Observational
4.4.3. Expanded Access
Chapter 5. Virtual Clinical Trials Market: Segment Analysis, By Indication, 2016 - 2027 (USD Million)
5.1. Segment Dashboard
5.2. Indication Market Share Analysis, 2019 & 2027
5.3. Global Virtual Clinical Trials Market, By Indication, 2016 to 2027
5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following:
5.4.1. Oncology
5.4.2. Cardiovascular
5.4.3. Others
Chapter 6. Virtual Clinical Trials Market: Regional Market Analysis, 2016 - 2027 (USD Million)
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2019 & 2027
6.3. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.4. North America
6.4.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.4.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.4.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.4.4. U.S.
6.4.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.4.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.4.5. Canada
6.4.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.4.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.5. Europe
6.5.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.5.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.5.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.5.4. Germany
6.5.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.5.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.5.5. U.K.
6.5.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.5.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.5.6. France
6.5.6.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.5.6.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.5.7. Italy
6.5.7.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.5.7.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.5.8. Spain
6.5.8.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.5.8.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.6. Asia Pacific
6.6.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.6.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.6.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.6.4. India
6.6.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.6.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.6.5. Japan
6.6.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.6.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.6.6. China
6.6.6.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.6.6.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.6.7. Australia
6.6.7.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.6.7.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.6.8. South Korea
6.6.8.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.6.8.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.7. Latin America
6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.7.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.7.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.7.4. Brazil
6.7.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.7.5. Mexico
6.7.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.7.6. Argentina
6.7.6.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.7.6.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.7.7. Colombia
6.7.7.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.7.7.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.8. Middle East and Africa
6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.8.2. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.8.3. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.8.4. South Africa
6.8.4.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.8.5. Saudi Arabia
6.8.5.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
6.8.6. UAE
6.8.6.1. Market estimates and forecast, by study design, 2016 - 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by indication, 2016 - 2027 (USD Million)
Chapter 7. Virtual Clinical Trials Market: Competitive Analysis
7.1. Key companies profiled
7.1.1. ICON, plc
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. PAREXEL International Corporation
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. IQVIA
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Covance
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. PRA Health Sciences
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. LEO Innovation Lab
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Medidata
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Oracle
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. CRF Health
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Clinical Ink
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.1.11. Medable
7.1.11.1. Company Overview
7.1.11.2. Financial Performance
7.1.11.3. Product Benchmarking
7.1.11.4. Strategic Initiatives



List of Tables



Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Virtual Clinical Trials Market, By Region, 2016 - 2027 (USD Million)
Table 4 Global Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 5 Global Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 6 North America Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
Table 7 North America Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 8 North America Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 9 U.S. Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 10 U.S. Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 11 Canada Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 12 Canada Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 13 Europe Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
Table 14 Europe Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 15 Europe Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 16 U.K. Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 17 U.K. Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 18 Germany Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 19 Germany Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 20 France Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 21 France Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 22 Italy Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 23 Italy Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 24 Spain Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 25 Spain Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 26 Asia Pacific Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
Table 27 Asia Pacific Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 28 Asia Pacific Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 29 India Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 30 India Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 31 Japan Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 32 Japan Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 33 China Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 34 China Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 35 Australia Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 36 Australia Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 37 South Korea Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 38 South Korea Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 39 Latin America Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
Table 40 Latin America Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 41 Latin America Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 42 Brazil Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 43 Brazil Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 44 Mexico Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 45 Mexico Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 46 Argentina Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 47 Argentina Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 48 Colombia Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 49 Colombia Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 50 MEA Virtual Clinical Trials Market, By Country, 2016 - 2027 (USD Million)
Table 51 MEA Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 52 MEA Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 53 South Africa Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 54 South Africa Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 55 Saudi Arabia Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 56 Saudi Arabia Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)
Table 57 UAE Virtual Clinical Trials Market, By Study Design, 2016 - 2027 (USD Million)
Table 58 UAE Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million)